Drug Bans Require Central Government Action Under D&C Act, Local Inspectors Cannot Unilaterally Prohibit: Supreme Court

The Supreme Court of India has unequivocally ruled that the authority to ban or restrict drugs rests solely with the Central Government under the Drugs and Cosmetics Act, 1940 (D&C Act). In a significant decision, the Court set aside actions by local authorities attempting to prohibit the sale of aromatic tincture of cardamom without requisite central notification. 

The judgment was delivered by a bench comprising Justice Vikram Nath and JusticePrasanna B. Varale in the case of M/S Bhagwati Medical Hall & Anr. vs. Central Drugs Standard Control Organization & Ors. (Civil Appeal Nos. 14735-14736 of 2024). The ruling clarified critical legal principles concerning the scope of authority under the D&C Act.

Background of the Case

Play button

The appellants, M/S Bhagwati Medical Hall and another, proprietors of medical shops in Agra, Uttar Pradesh, challenged restrictions imposed by state authorities, including the District Magistrate and Drug Inspector, on the sale of aromatic tincture of cardamom. Despite holding valid licenses under the D&C Act, they faced allegations that the tincture—due to its high alcohol content—was being misused as an intoxicant by vulnerable populations.

READ ALSO  Passport Impounding Requires Reasoned Order, Not Mere Pendency of Criminal Case: Allahabad High Court

The appellants, represented by advocate Shri Nikhil Goel, contended that their lawful trade was arbitrarily disrupted, violating their fundamental right to carry on business under Article 19(1)(g) of the Constitution. They emphasized that no notification under Section 26A of the D&C Act had been issued to restrict or ban the tincture, making the actions of the state authorities legally unsustainable.

Legal Issues

1. Scope of Local Authorities’ Powers Under the D&C Act  

   The primary legal question revolved around whether local authorities, such as the District Magistrate and Drug Inspectors, could prohibit the sale of a licensed medicinal preparation without central authorization.

2. Applicability of Section 26A of the D&C Act  

   The Court examined whether the absence of a central notification under Section 26A of the D&C Act rendered the actions of local authorities ultra vires.

3. Violation of Fundamental Rights  

   The appellants argued that the restrictions infringed upon their constitutional right to conduct lawful business under Article 19(1)(g).

READ ALSO  POCSO Act Not Meant to Criminalize Consensual Romantic Relationships Between Adolescents: Allahabad High Court

Supreme Court’s Observations

The Supreme Court made several key observations:

1. Centralization of Prohibitory Powers  

   The Court held that under Section 26A of the D&C Act, only the Central Government is empowered to impose prohibitions on drugs, ensuring uniformity and preventing arbitrary local actions. The judgment noted:  

“Without a central notification, any attempt by local officials to treat a lawful drug as a prohibited article undermines the legislative intent and statutory scheme of the D&C Act.”

2. Limits of Local Authority Jurisdiction  

   The Court clarified that the powers of local Drug Inspectors under Section 22(1)(d) of the D&C Act are procedural, allowing inspections and enforcement of existing regulations. These powers do not extend to unilaterally declaring a licensed drug as prohibited.

3. Safeguards Against Arbitrary Actions  

   The bench underscored that any restriction on a drug must follow a centralized, scientifically informed process involving expert advice and notifications under Section 26A, which serves as a statutory safeguard against arbitrary measures.

4. Protection of Lawful Trade  

   Emphasizing the appellants’ right to carry on business in a lawful manner, the Court observed:  

READ ALSO  Subsequent Purchaser Has No Right to Claim Lapse of Land Acquisition Proceedings: Supreme Court

“Fundamental principles of administrative law, as well as the very structure of the D&C Act, demand that any restriction on a licensed medicinal preparation must rest on a firm statutory footing.”

Decision 

Allowing the appeals, the Supreme Court quashed the impugned orders of the High Court and state authorities, directing them to cease any interference with the appellants’ business. It further ruled that the appellants, holding valid licenses, were entitled to resume their trade without hindrance.

In its concluding remarks, the Court emphasized the need for a uniform regulatory regime:  

“The statutory scheme envisions uniformity, predictability, and legal certainty—values that would be undermined if local authorities could unilaterally impose prohibitions contrary to the nationally determined regime.”

Law Trend
Law Trendhttps://lawtrend.in/
Legal News Website Providing Latest Judgments of Supreme Court and High Court

Related Articles

Latest Articles